author-photo

Lorna Castaneda

Bristol-Myers Squibb

10

Papers

297

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat

2013 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (12)
A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects

2012 Clinical Pharmacokinectics
Show All
- Source
- Cite
- Save
Citations (36)
Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin

2011 Clinical Pharmacokinectics
Show All
- Source
- Cite
- Save
Citations (85)
The safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of BMS-708163 in young and elderly subjects

2010 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (2)
P0586 A COMPARISON OF THE SINGLE-DOSE PHARMACOKINETICS AND SAFETY OF SAXAGLIPTIN IN SUBJECTS WITH HEPATIC IMPAIRMENT AND IN HEALTHY SUBJECTS

2009 European Journal of Internal Medicine
Show All
- Source
- Cite
- Save
Citations (6)